RESUMEN
BACKGROUND: Anesthesia providers have long been pioneers in patient safety. Despite remarkable efforts, anesthesia errors still occur, resulting in complications, injuries, and even death. The Veterans Health Administration (VHA) National Center of Patient Safety uses root cause analysis (RCA) to examine why system-related adverse events occur and how to prevent future similar events. This study describes the types of anesthesia adverse events reported in VHA hospitals and their root causes and preventative actions. METHODS: RCA reports from VHA hospitals from May 30, 2012, to May 1, 2015, were reviewed for root causes, severity of patient outcomes, and actions. These elements were coded by consensus and analyzed using descriptive statistics. RESULTS: During the study period, 3228 RCAs were submitted, of which 292 involved an anesthesia provider. Thirty-six of these were specific to anesthesia care. We reviewed these 36 RCA reports of adverse events specific to anesthesia care. Types of event included medication errors (28%, 10), regional blocks (14%, 5), airway management (14%, 5), skin integrity or position (11%, 4), other (11%, 4), consent issues (8%, 3), equipment (8%, 3), and intravenous access and anesthesia awareness (3%, 1 each). Of the 36 anesthesia events reported, 5 (14%) were identified as being catastrophic, 10 (28%) major, 12 (34%) moderate, and 9 (26%) minor. The majority of root causes identified a need for improved standardization of processes. CONCLUSIONS: This analysis points to the need for systemwide implementation of human factors engineering-based approaches to work toward further eliminating anesthesia-related adverse events. Such actions include standardization of processes, forcing functions, separating storage of look-alike sound-alike medications, limiting stock of high-risk medication strengths, bar coding medications, use of cognitive aids such as checklists, and high-fidelity simulation.
Asunto(s)
Sistemas de Registro de Reacción Adversa a Medicamentos , Anestesia/efectos adversos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/diagnóstico , Hospitales de Veteranos , Análisis de Causa Raíz/métodos , United States Department of Veterans Affairs , Sistemas de Registro de Reacción Adversa a Medicamentos/tendencias , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Hospitales de Veteranos/tendencias , Humanos , Seguridad del Paciente , Análisis de Causa Raíz/tendencias , Administración de la Seguridad/métodos , Administración de la Seguridad/tendencias , Estados Unidos/epidemiología , United States Department of Veterans Affairs/tendencias , Salud de los Veteranos/tendenciasRESUMEN
OBJECTIVE: The purpose of this study was to examine the effects of sevoflurane cardioplegia on neutrophil response and complement activation after cardiopulmonary bypass (CPB). DESIGN: A prospective, randomized clinical investigation. SETTING: University-affiliated hospital; single institutional. PARTICIPANTS: Twenty-one male patients undergoing coronary bypass surgery using CPB. INTERVENTIONS: Eleven patients were randomly assigned to receive sevoflurane 2% as a part of the cardioplegic mixture (SEV). The control group (n = 10) received no sevoflurane in their cardioplegia (control). MEASUREMENTS AND MAIN RESULTS: Myeloperoxidase activity (MPO) was assayed in coronary sinus blood as a surrogate for neutrophilic response at the termination of CPB. MPO activity in the coronary sinus blood was lower in the patients who received sevoflurane compared with controls. MPO activity was higher in patients with cardiac events at 4-year follow-up when compared with asymptomatic patients. IL-8, C4b, C3d, C5a, and CH50 were assessed in coronary sinus and peripheral blood at time of CPB initiation (T0) and upon the termination of CPB (T2). Peripheral blood sampling occurred at the sixth hour after T0 (T6). IL-8 levels were significantly inhibited in the SEV group when compared with controls at T2 and T6. CH50 (an index of global activation of complement system) decreased 30% at T2 and 52% at T6. The classic component of the complement pathway (C4b) was effectively inhibited in the SEV group, whereas the common pathway (C3d and C5a) was similar in both groups. CONCLUSIONS: The addition of sevoflurane to cardioplegia is associated with an inhibition of neutrophils after CPB. A major component of the neutrophil response appears to be IL-8 mediated, although the classic complement pathway is also inhibited by sevoflurane.
Asunto(s)
Puente Cardiopulmonar , Paro Cardíaco Inducido , Éteres Metílicos/farmacología , Activación Neutrófila/efectos de los fármacos , Activación de Complemento , Complemento C5a/análisis , Humanos , Interleucina-8/sangre , Masculino , Peroxidasa/sangre , Canales de Potasio/fisiología , Estudios Prospectivos , SevofluranoRESUMEN
OBJECTIVE: To examine the role of sevoflurane in myocardial protection in patients undergoing coronary artery bypass graft (CABG) surgery. DESIGN: Prospective, randomized, controlled, double-blinded study. SETTING: Veterans Administration Medical Center (VAMC), Buffalo, New York. SUBJECTS: Twenty-one patients undergoing CABG were included in the study. Eleven patients were randomized to receive sevoflurane, and 10 patients served as controls. INTERVENTION: Total intravenous anesthesia was provided for both study and control groups by infusion of propofol, fentanyl, and midazolam. Sevoflurane 2% was added to the cardioplegia solution in the experimental group. MEASUREMENTS AND MAIN RESULTS: Neutrophil beta-integrins (CD11b/CD18), tumor necrosis factor alpha (TNF-alpha), and interleukin (IL)-6 were measured as indicators of the inflammatory response to myocardial ischemia-reperfusion injury. Blood samples were obtained from the aorta and coronary sinus before (T1) and immediately after cardiopulmonary bypass (CPB) (T2) and, in addition, from a peripheral artery 6 hours (T3) after CPB. Myocardial function was determined in all patients at each time point. Left ventricular stroke work index (LVSWI) was calculated as an estimation of left ventricular function. Left ventricular regional wall motion abnormality (RWMA) was assessed by transesophageal echocardiography at T1 and T2 time points. TNF-alpha was detectable only in the control group in arterial samples at T3. IL-6 levels (pg/mL) were found to be lower in the sevoflurane group compared with controls at T2 arterial circulation (38.2 +/- 21.1 v 60.6 +/- 19.1, p < 0.05) as well as in the coronary circulation (38.4 +/- 19.9 v 118.2 +/- 23.5, p < 0.01) at T2. CD11b/CD18 increased 79% after CPB in the control group while only increasing 36% in the sevoflurane group (p < 0.05). The post-CPB LVSWI was back to its baseline values in the sevoflurane group, whereas it was still significantly depressed in the control group. Eight of 10 patients in the control group showed a transient new-onset RWMA in either the septal or anteroseptal regions. Only 2 of 11 patients in the sevoflurane group showed transient RWMA of the LV. CONCLUSIONS: Sevoflurane decreases the inflammatory response after CPB, as measured by the release of IL-6, CD11b/CD18, and TNF-alpha. Myocardial function after CPB, as assessed by RWMA and LVSWI, was also improved with sevoflurane. The role of sevoflurane in myocardial protection and the inflammatory response to myocardial reperfusion should be considered.
Asunto(s)
Anestesia Intravenosa , Anestésicos por Inhalación/administración & dosificación , Puente de Arteria Coronaria , Éteres Metílicos/administración & dosificación , Daño por Reperfusión Miocárdica/prevención & control , Anciano , Antígenos CD11/sangre , Antígenos CD18/sangre , Soluciones Cardiopléjicas/administración & dosificación , Puente Cardiopulmonar , Método Doble Ciego , Hemodinámica , Humanos , Interleucina-6/sangre , Persona de Mediana Edad , Daño por Reperfusión Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/fisiopatología , Sevoflurano , Factor de Necrosis Tumoral alfa/análisis , Función Ventricular IzquierdaRESUMEN
OBJECTIVES/HYPOTHESIS: This study was designed to explore the relationship between changes in middle ear pressure associated with inhalational anesthesia and the incidence of postoperative nausea and vomiting (PONV). STUDY DESIGN: Prospective, randomized. METHODS: Middle ear compartment pressures were measured by tympanometry in 27 randomly assigned knee arthroscopy patients throughout the surgical procedure as well as into recovery. RESULTS: A positive correlation between the maximum positive pressure (MPP) and maximum negative pressure (MNP) gradient and PONV was demonstrated (P <.05). The incidence of PONV in the nitrous oxide (N2O) treatment group was 6 of 16 patients, whereas only 2 of 11 patients in the control group developed nausea, vomiting, and vertigo symptoms. Those patients that did not experience PONV demonstrated a median MPP of 155 with a median MNP of -52. The patients that experienced PONV exhibited a median MPP of 179 with a median MNP of -164. This demonstrates a significant increase in the incidence of PONV in the N2O treatment group. CONCLUSIONS: Barometric changes in the middle ear contribute to the incidence of PONV induced by N2O.